Ambrx Biopharma Total Assets 2020-2023 | AMAM
Ambrx Biopharma total assets from 2020 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
Ambrx Biopharma Annual Total Assets
(Millions of US $) |
| 2022 |
$147 |
| 2021 |
$229 |
| 2020 |
$134 |
| 2019 |
$62 |
Ambrx Biopharma Quarterly Total Assets
(Millions of US $) |
| 2023-03-31 |
$211 |
| 2022-12-31 |
$147 |
| 2022-03-31 |
$0 |
| 2021-12-31 |
$229 |
| 2021-06-30 |
$214 |
| 2020-12-31 |
$134 |
| 2019-12-31 |
$62 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.802B |
$0.007B |
|
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
|
